Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mildly Impaired Renal Function”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03913000
What this trial is testing

Evaluate ID-085 in People With Mild, Moderate, and Severe Kidney Disease

Who this might be right for
Renal Impairment
Idorsia Pharmaceuticals Ltd. 32
Early research (Phase 1)Study completedNCT03259087
What this trial is testing

Pharmacokinetics (PK) and Safety of a Single Intravenous (IV) Dose of MK-3866 in Participants With Impaired Renal Function and in Healthy Controls (MK-3866-005)

Who this might be right for
Renal Impairment
Merck Sharp & Dohme LLC 42
Early research (Phase 1)Study completedNCT01444872
What this trial is testing

Study to Evaluate TRV120027 on Renal Pharmacodynamics in Patients With Heart Failure and Renal Dysfunction

Who this might be right for
Heart FailureKidney Disease
Trevena Inc. 17
Post-approval studies (Phase 4)UnknownNCT01820832
What this trial is testing

Oral Calcitriol for Reduction of Mild Proteinuria in Patients With CKD

Who this might be right for
Chronic Kidney DiseaseProteinuria
Huashan Hospital 60
Early research (Phase 1)Study completedNCT03814005
What this trial is testing

Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver Problems

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myelomonocytic, ChronicLeukemia, Myeloid, Acute+3 more
Takeda 17
Early research (Phase 1)Not Yet RecruitingNCT07445906
What this trial is testing

RG002C0106 Injection in Adult Participants With Normal Renal Function and Mild-to-Moderate Renal Impairment

Who this might be right for
Renal ImpairmentsIgA Nephropathy (IgAN)
Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Co., Ltd. 24
Post-approval studies (Phase 4)Study completedNCT01172431
What this trial is testing

Indapamide Versus Hydrochlorothiazide in Elderly Hypertensive Patients With Renal Insufficiency

Who this might be right for
HypertensionRenal Insufficiency
West China Hospital 240
Not applicableStudy completedNCT07133256
What this trial is testing

Effects of Aerobic Versus Resistance Training on Bone Metabolism in Stage 3-4 Chronic Kidney Disease

Who this might be right for
OsteopeniaBone Metabolism DisordersChronic Kidney Disease (Stage 3-4)+1 more
Sinai University 60
Early research (Phase 1)Study completedNCT00999336
What this trial is testing

Determine the Pharmacokinetics, Pharmacodynamics, and Tolerabiltiy of Betrixaban in Patients With Mild, Moderate, and Severe Renal Impairment

Who this might be right for
Renal Impairment
Portola Pharmaceuticals 32
Large-scale testing (Phase 3)Study completedNCT02532855
What this trial is testing

Assess the Addition of Sitagliptin to Metformin Compared With the Addition of Dapagliflozin to Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) and Mild Renal Impairment Who Have Inadequate Glycemic Control on Metformin With or Without a Sulfonylurea (MK-0431-838)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 614
Early research (Phase 1)Study completedNCT05431426
What this trial is testing

PK of CHF6001 in Subjects With Mild, Moderate and Severe Renal Impairment vs. Healthy Volunteers

Who this might be right for
Chronic Obstructive Pulmonary Disease
Chiesi Farmaceutici S.p.A. 44
Early research (Phase 1)Study completedNCT01569815
What this trial is testing

Pharmacokinetics of LCZ696 in Subjects With Mild and Moderate Renal Impairment Compared to Healthy Subjects With Normal Renal Function

Who this might be right for
Mild and Moderate Renal Impairment
Novartis Pharmaceuticals 32
Early research (Phase 1)Study completedNCT05117294
What this trial is testing

ASP0367 in People With Kidneys That do Not Work Well and in Healthy People

Who this might be right for
Renal ImpairmentHealthy Volunteers
Astellas Pharma Global Development, Inc. 13
Testing effectiveness (Phase 2)Study completedNCT03115736
What this trial is testing

TAF for HIV-HBV With Renal Dysfunction

Who this might be right for
HIV and Hepatitis B Coinfection
Insel Gruppe AG, University Hospital Bern 24
Not applicableUnknownNCT05104593
What this trial is testing

An Integrated Solution for Sustainable Care for Multimorbid Elderly Patients With Dementia

Who this might be right for
Comorbidities and Coexisting ConditionsAlzheimer DiseaseDementia+12 more
Complejo Hospitalario Universitario de Albacete 204
Large-scale testing (Phase 3)Study completedNCT00273871
What this trial is testing

Study Comparing Conversion From Calcineurin Inhibitors to Rapamune Versus Standard Therapy in Established Renal Allograft Recipients

Who this might be right for
Graft RejectionKidney FailureKidney Transplantation
Wyeth is now a wholly owned subsidiary of Pfizer 190
Early research (Phase 1)Study completedNCT03097016
What this trial is testing

Assess the Pharmacokinetics of CC-122 in Subjects With Mild, Moderate, and Severe Renal Impairment

Who this might be right for
Renal Insufficiency
Celgene 48
Early research (Phase 1)Study completedNCT04476407
What this trial is testing

Pharmacokinetics of Benapenem in Subjects With Renal Impairment

Who this might be right for
Complicated Urinary Tract Infection; Cuti
Sihuan Pharmaceutical Holdings Group Ltd. 18
Not applicableStudy completedNCT01721837
What this trial is testing

Dabigatran Etexilate for Stroke Prevention in Patients With Atrial Fibrillation and Mild to Moderate Renal Impairment

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 4,340
Early research (Phase 1)Study completedNCT01442259
What this trial is testing

An Open-label, Parallel-group Study to Determine the Pharmacokinetics of a Single Dose of AFQ056 in Subjects With Renal Impairment Compared to Healthy Subjects

Who this might be right for
Mild Moderateor Severe Renal Impairment
Novartis Pharmaceuticals 48
Next Page